News und Analysen
DGAP-News: BP p.l.c.: Transaction in Own Shares
Granite REIT Declares Distribution for February 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced the appointment
Lysogene Reports Additional Positive Biomarker Data With LYS-SAF302 and Favorable Safety Data With LYS-GM101 Presented at the WORLDSymposium™ 2022
Regulatory News:
Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today reports positive biomarker data from the ongoing
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)
CI Global Asset Management Announces February 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending February 28, 2022 in respect of the CI ETFs. In all cases, the distribution will be
CI Financial Advances Leadership Position in Crypto Offering with Investment in Newton Crypto
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today announced it has made a strategic investment in Newton Crypto Ltd. (“Newton”), a leading Canadian crypto asset trading platform.
CI acquired
DGAP-Adhoc: BP p.l.c.: Share Repurchases
DGAP-Adhoc: BP p.l.c.: Share Repurchases
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced an update to
DGAP-Adhoc: BP p.l.c.: bp update on strategic progress
DGAP-Adhoc: BP p.l.c.: bp update on strategic progress
DGAP-Adhoc: BP p.l.c.: Final Results
DGAP-Adhoc: BP p.l.c.: Final Results
Lysogene Provides Medical Update
Regulatory News:
Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today provides a medical update.
First
Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to
CI Galaxy Launches Multi-Crypto ETF with the World’s Lowest Management Fee
CI Global Asset Management (“CI GAM”) announces the launch of CI Galaxy Multi-Crypto ETF, which is designed to capture the upside of investing in the world’s two top cryptocurrencies while managing
CI Financial Announces Fourth Quarter Earnings Conference Call and Webcast
CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) will release its financial results for the fourth quarter of fiscal 2021 on Tuesday, February 22, 2022.
CI will hold a conference call with
CI Global Asset Management Funds and ETFs Recognized for Investment Excellence
CI Global Asset Management (“CI GAM”) announces it has received 38 FundGrade A+® Awards, which are presented annually by Fundata Canada Inc. to acknowledge Canadian investment funds that have
CI Financial’s Total Assets Grow by $152.5 billion in 2021 to Record $384.1 Billion
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary assets under management as at December 31, 2021 of $152.1 billion and wealth management assets of $232.0 billion, for
Granite REIT Declares Distribution for January 2022
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of
Aragon Research Positions Qumu in the Leader Section of the 2022 Research Globe for Enterprise Video
Qumu Corporation (Nasdaq: QUMU), a leading provider of cloud-based enterprise video technology, today announced it has been positioned by Aragon Research, Inc. in the Leader section of the 2022
CI Global Asset Management Announces January 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending January 31, 2022 in respect of CI ETFs. In all cases, the distribution will be paid on